These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9873781)

  • 21. Cost related to replacement therapy during hospitalization in haemophiliacs with or without inhibitors: experience of six French haemophilia centres.
    Gautier P; D'Alche-Gautier MJ; Coatmelec B; Marques-Verdier A; Bertrand MA; Dieval J; Berthier AM
    Haemophilia; 2002 Sep; 8(5):674-9. PubMed ID: 12199678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose tertiary prophylactic therapy reduces total number of bleeds and improves the ability to perform activities of daily living in adults with severe haemophilia A: a single-centre experience from Beijing.
    Hua B; Lian X; Li K; Lee A; Poon MC; Zhao Y
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):136-40. PubMed ID: 26258677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. European retrospective study of real-life haemophilia treatment.
    Berntorp E; Dolan G; Hay C; Linari S; Santagostino E; Tosetto A; Castaman G; Álvarez-Román MT; Parra Lopez R; Oldenburg J; Albert T; Scholz U; Holmström M; Schved JF; Trossaërt M; Hermans C; Boban A; Ludlam C; Lethagen S
    Haemophilia; 2017 Jan; 23(1):105-114. PubMed ID: 27761962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of joint damage in hemophilic children with early prophylaxis].
    Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
    Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of children with severe haemophilia A and inhibitors: a health economic evaluation for Germany.
    Berger K; Schopohl D; Eheberg D; Auerswald G; Kurnik K; Schramm W
    Klin Padiatr; 2013 May; 225(3):152-8. PubMed ID: 23519749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health status and health-related quality of life of children with haemophilia from six West European countries.
    Gringeri A; von Mackensen S; Auerswald G; Bullinger M; Perez Garrido R; Kellermann E; Khair K; Lenk H; Vicariot M; Villar A; Wermes C;
    Haemophilia; 2004 Mar; 10 Suppl 1():26-33. PubMed ID: 14987246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003429. PubMed ID: 15846666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemophilia care in Europe: the ESCHQoL study.
    Schramm W; Gringeri A; Ljung R; Berger K; Crispin A; Bullinger M; Giangrande PL; Von Mackensen S; Mantovani LG; Nemes L; Serban M;
    Haemophilia; 2012 Sep; 18(5):729-37. PubMed ID: 22639833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic issues in European self-sufficiency.
    Szucs TD
    Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S51-5. PubMed ID: 7795140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is haemophilia prophylaxis achievable in the context of self-sufficiency?
    Nilsson IM
    Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S71-5. PubMed ID: 7795143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Need for Prophylactic Treatment in Adult Haemophilia A Patients.
    Siegmund B; Richter H; Pollmann H
    Transfus Med Hemother; 2009; 36(4):283-288. PubMed ID: 20877667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.
    Carlsson KS; Höjgård S; Lindgren A; Lethagen S; Schulman S; Glomstein A; Tengborn L; Berntorp E; Lindgren B
    Haemophilia; 2004 Sep; 10(5):515-26. PubMed ID: 15357779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic use of factor VIII: an economic evaluation.
    Bohn RL; Avorn J; Glynn RJ; Choodnovskiy I; Haschemeyer R; Aledort LM
    Thromb Haemost; 1998 May; 79(5):932-7. PubMed ID: 9609224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation of healthcare utilisation and cost of haemophilia care in real-life: A 4-year follow-up study in Finland.
    Ventola H; Vesikansa A; Jokelainen J; Siitonen T; Ettala P; Laine O; Lehtinen E; Lepäntalo A; Patronen M; Partanen A; Linna M; Ylisaukko-Oja T; Lassila R
    Haemophilia; 2021 Jan; 27(1):e30-e39. PubMed ID: 33216410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-standing prophylactic therapy vs. episodic treatment in young people with severe haemophilia: a comparison of age-matched Danish and Russian patients.
    Ingerslev J; Lethagen S; Hvitfeldt Poulsen L; Sørensen B; Lopatina E; Tentsova I; Yastrubinetskaya O; Plyushch OP
    Haemophilia; 2014 Jan; 20(1):58-64. PubMed ID: 24354479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of prophylaxis against on-demand treatment in boys with severe hemophilia A in Iran.
    Daliri AA; Haghparast H; Mamikhani J
    Int J Technol Assess Health Care; 2009 Oct; 25(4):584-7. PubMed ID: 19845990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic and epidemiological modelling of full-length antihaemophilic factor (recombinant), plasma/albumin-free method, in previously treated patients with haemophilia A : comparison with B-domain deleted rFVIII, and value of potential viral transmission reduction due to plasma/albumin-free status.
    Sclar DA; Evans MA; Skaer TL; Robison LM; Chung KC; Poulios NS
    Drugs R D; 2005; 6(3):149-56. PubMed ID: 15869318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis vs. on-demand treatment with Nuwiq(®) (Human-cl rhFVIII) in adults with severe haemophilia A.
    Tiede A; Oldenburg J; Lissitchkov T; Knaub S; Bichler J; Manco-Johnson MJ
    Haemophilia; 2016 May; 22(3):374-80. PubMed ID: 26582282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the effectiveness and cost-effectiveness of prophylaxis against bleeding in patients with severe haemophilia and severe von Willebrand's disease.
    Miners AH; Sabin CA; Tolley KH; Lee CA
    J Intern Med; 1998 Dec; 244(6):515-22. PubMed ID: 9893105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological survey of haemophiliacs with inhibitors in France: orthopaedic status, quality of life and cost--the 'Statut Orthopédique des Patients Hémophiles' avec Inhibiteur study.
    Stieltjes N; Torchet MF; Misrahi L; Roussel-Robert V; Lambert T; Guérois C; Bertrand MA; Briquel ME; Borel-Derlon A; Dirat G
    Blood Coagul Fibrinolysis; 2009 Jan; 20(1):4-11. PubMed ID: 20527720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.